Kidney Res Clin Pract > Epub ahead of print
Andrade, Heitmann, Rodrigues, Marchand, Rodrigues, Biluca, Freitas, Reis, Goes, and Oliveira: Exercise as an adjunctive therapy for patients on maintenance hemodiafiltration

Abstract

Background

Fatigue and sedentarism are common in kidney disease and dialysis treatment. Although hemodiafiltration effectively removes solutes and improves mortality, the influence of exercise as an adjunct therapy on maintenance hemodiafiltration programs remains understudied.

Methods

A multicenter 6-month study was assessed comparing individuals with chronic kidney disease enrolled in exercise training (exercise group) during dialysis (intradialytic vs. interdialytic) compared to usual care (control group). Physical tests included a YMCA step test for endurance, handgrip, and one-repetition maximum for muscle strength. Single-pool, standard, and equilibrated Kt/Vurea were surrogates for hemodiafiltration adequacy.

Results

Eighty-nine patients (aged 54 ± 15 years) and 33 control patients (aged 60 ± 17 years) underwent the exercise protocol. The mean disease vintage was 108 ± 84 and 132 ± 108 months, respectively, while the dialysis vintage was 60 ± 42 and 60 ± 36 months. Control-group Kt/Vurea showed improvement from baseline to month 6 (single-pool, 1.18 ± 0.03 to 1.30 ± 0.04; standard, 1.94 ± 0.04 to 2.09 ± 0.04; equilibrated, 1.09 ± 0.03 to 1.21 ± 0.02; p < 0.001). However, exercise-group Kt/Vurea showed a comparatively greater improvement between the baseline and month 6 (single pool, 1.19 ± 0.05 to 1.47 ± 0.04; standard, 1.99 ± 0.03 to 2.15 ± 0.03; equilibrated, 1.08 ± 0.03 to 1.24 ± 0.03; p < 0.001). The exercise group had a statistically significant increase in the handgrip test (279.5 ± 78.5 N to 295.2 ± 76.5 N, p < 0.01) and fat-free mass (13.9 ± 2.8 kg/m2 to 14.4 ± 2.7 kg/m2, p < 0.01). There were no statistically significant differences between the interdialytic and intradialytic groups in dialysis adequacy and exercise variables.

Conclusion

Supervised exercise for maintenance hemodiafiltration patients was associated with improvements in dialysis efficiency/performance outcomes. The results support exercise as an adjunct therapy for hemodiafiltration patients whether conducted during the intradialytic or interdialytic period.

Introduction

Chronic kidney disease affects approximately 7% of the world’s population with an expected increase in dialytic treatments annually [1]. Hemodiafiltration is a dialysis option that has demonstrated the highest capacity for removing small solutes and middle molecules. Additionally, high-volume hemodiafiltration has been associated with potential increased survival benefits in some studies [2,3].
Advanced kidney disease patients on hemodialysis often experience functional losses such as fatigue, muscle wasting, cognitive decline, and diminished aerobic capacity, impacting their physical activity, quality of life, and mortality [4]. In addition, dialysis sessions also contribute to low physical activity due to related symptoms of the procedure. Therefore, preserving function and quality of life is a priority for these patients. Exercise training and physical activity are increasingly popular to mitigate chronic diseases and reduce symptoms in patients with chronic conditions [5,6]. However, current literature regarding chronic kidney disease patients and exercise implementation focuses on hemodialysis, rather than hemodiafiltration.
Earlier studies have explored various aspects of exercise in relation to hemodialysis, including aerobic exercise, muscle strength, and program duration [711]. Research has also investigated the impact of exercise on hemodialysis quality, examining factors such as inflammation markers, sarcopenia, and cardiovascular capacity [5,1214]. Additionally, physical activity does positively correlate to improved mental health, sleep quality, and physical function of daily activities [15,16]. There is evidence that indicates exercise improves physical abilities and quality of life during dialytic sessions [7,8,1720]. However, there is no current evidence that supports hemodiafiltration patients benefiting from exercise. Furthermore, there is a gap in the literature regarding when exercise should be performed, during the dialysis sessions or the interdialytic interval.
This study’s goals were to first, understand if the combination of hemodiafiltration and exercise was an efficacious treatment compared to usual care in chronic kidney failure. Second, to explore the effectiveness of exercise within dialysis sessions (intradialytic) or between dialysis sessions (interdialytic).

Methods

An observational multicenter study was conducted within the chronic kidney disease patient cohort at the Fenix Nephrology Group. The study population comprised sedentary adult males and females undergoing maintenance hemodiafiltration. Inclusion criteria involved patients with optimized medication treatment and willingness to participate in the exercise program.
All patients at the Fenix Nephrology clinics were invited to participate in the rehabilitation program without exception. Patients self-selected into either the exercise or control group based on their willingness to participate. Those who chose to exercise further decided whether to perform the protocol during (intradialytic) or between (interdialytic) dialysis sessions. Once this choice was made, patients were encouraged to maintain their selected timing throughout the study duration to ensure consistency in the protocol. A control group consisted of individuals in the study who did not perform the exercise protocol and did not receive a physical evaluation from a physical therapist. In addition, prior to the initiation of the study, all participants, including those in the control group, were assessed for their physical activity levels and confirmed to be sedentary. Data collected from this study group only pertained to dialysis adequacy.
Patients were assessed at the initiation of the exercise program (baseline), and again after 6 months. Exclusion criteria encompassed patients with less than 80% attendance to the exercise program, those who underwent kidney transplantation during the study period, and patients with missing data in their medical records. This study was approved by the Federal University of Sao Paulo – UNIFESP Research Ethics Committee (No. 60256122.0.0000.5505) and was registered in the Registry of Clinical Trials (NCT#06448598). All participants signed the informed consent.
Physical assessments (aerobic and resistance) involved the Young Men’s Christian Association (YMCA) step test for endurance, handgrip, and one-repetition maximum for muscle strength. Tests were conducted by a trained team following a standardized protocol across all centers. The team received extensive training and detailed guidance to ensure standardization of measurements across centers. Patient-reported outcomes were evaluated using the Kidney Disease Quality of Life Short Form (KDQOL-SF). Dialysis adequacy was assessed using three Kt/V measures: single-pool Kt/V (spKt/V), standard Kt/V (stdKt/V), and equilibrated Kt/V (eKt/V). The formulae [21] used for these calculations were:
spKt/V = –ln (R0.008 × t) + (43.5 × R) × UF/W (where R is the post-/pre-dialysis blood urea nitrogen ratio, t is the dialysis time in hours, UF is the ultrafiltration volume in liters, and W is the post-dialysis weight in kg)
stdKt/V = spKt/V × (10.47/t)
eKt/V = spKt/V0.6 (spKt/V/t) + 0.03

Exercise protocol

Patients meeting the inclusion criteria decided to carry out the exercise activities either during the hemodiafiltration session (intradialytic) or during the interdialytic interval (interdialytic) (Fig. 1). Interdialytic exercise activities were scheduled on days without planned hemodiafiltration sessions (patients had to come into the clinic for their exercise). Intradialytic sessions were seamlessly integrated into the hemodiafiltration session.
Patients adhered to a consistent exercise program, encompassing aerobic and resistance exercises, and both intradialytic and interdialytic exercise sessions that lasted 30 to 45 minutes. Aerobic exercises were performed at 70% of the maximum heart rate achieved in the YMCA step test, while resistance exercises were executed at 60% of the one-repetition maximum weight.
The exercise protocol was implemented across multiple Fenix Nephrology centers, with all physiotherapists receiving standardized training to ensure consistent application. Before each session, physiotherapists assessed patients’ clinical and physical conditions, including measurements of systolic and diastolic blood pressure, heart rate, and subjective perception of effort using the Borg scale [22]. Exercise intensity was adjusted based on these parameters to ensure patient safety and comfort.
For intradialytic exercise, sessions were seamlessly integrated into the hemodiafiltration treatment, with timing varying according to the patient’s clinical condition. Exercises were conducted at various periods throughout the session, including at the beginning, during, and near the end of the dialysis treatment. Patients used a bedside cycle ergometer for aerobic training, with workload adjusted according to individual tolerance. Resistance exercises utilized dumbbells, targeting major muscle groups with three sets of 10 to 12 repetitions (as determined by the 60% one-repetition maximum weight threshold), while avoiding the limb with arteriovenous fistula.
Interdialytic exercise sessions were performed on non-dialysis days, usually within 24 hours after the previous dialysis session. Interdialytic exercise offered patients a choice between a treadmill or cycle ergometer for aerobic training, with intensity tailored to patient tolerance. Resistance training incorporated dumbbells and ankle weights, following a similar protocol to intradialytic sessions.
Aerobic and resistance exercises were alternated between sessions to prevent overload and maintain clinical stability. The exercise regimen remained consistent for both groups, with loads adjusted weekly to maintain the correct intensity. The program spanned 6 months, with sessions occurring twice weekly. Throughout each session, the access limb was properly positioned and continuously monitored for patency, dysfunction, and potential complications, while vital signs were closely observed. This comprehensive approach ensured a balanced and adaptable exercise regimen for all participants.

Strength test and handgrip

Strength testing involved two components: assessment of one-repetition maximum for resistance exercise and handgrip strength evaluation. For patients with an arteriovenous fistula, the one-repetition maximum assessment was performed on the limb contralateral to the dialysis access, where we determined the maximum weight patients could lift for a single repetition while maintaining proper form. For patients with tunneled catheters, we followed a similar protocol, assessing the one-repetition maximum on a suitable limb that did not interfere with the catheter placement. Participants performed a warm-up and after a brief rest, three to five repetitions at 60% to 80% of the perceived maximum was performed. Subsequently, small increments were added until the participant could not complete a repetition with proper form [23]. The 1RM (one-repetition max­imum) was determined within three to five trials with rest periods of 2 to 3 minutes between attempts. This test aimed to evaluate the maximal strength of the participants, and was used for exercise prescription, following the American College of Sports Medicine protocol [24].
Handgrip strength was measured using a calibrated hydraulic hand dynamometer (Jamar; Lafayette Instrument Company) following standardized procedures [25]. Participants were seated with the elbow of the arm contralateral to the access flexed at 90°, the forearm in neutral position, and the wrist extended between 0° and 30° extension. Their hips and knees were also flexed at 90°. A maximal contraction was performed with the dominant hand and repeated a total of three times, with a 120-second rest provided between each attempt. The highest recorded value, in kg, from the three attempts was considered the final measurement.

Step test

The YMCA step test was conducted using a 30-cm step platform with no handrails. Participants were instructed to step up and down at their own pace for 3 minutes. They were encouraged to maintain the pace, with an examiner offering verbal encouragement throughout the test. Heart rate and arterial oxygen saturation (SpO2) were assessed continuously. A modified Borg scale [22] of perceived exertion and blood pressure were measured before, immediately after, and 2 minutes after the test. The test score was the 60-second recovery heart rate, measured while participants remained standing immediately after completing the steps. Lower recovery heart rates indicated better cardiovascular fitness. The peak heart rate obtained at the end of the step test was used as a reference for aerobic exercise prescription in the study [24].

Fat-free mass

Fat-free mass was assessed using the Seca MBCA 525 medical body composition analyzer with Analytics 115 software (Seca GmbH & Co. KG). This noninvasive device utilizes a multi-frequency phase-sensitive 8-electrode system for total body composition analysis. Four pairs of standard surface electrodes were placed on the hands and feet in anatomical positions, connected to a central analyzer linked to a computer.
All measurements were conducted immediately before dialysis for both interdialytic and intradialytic groups, with patients resting for 10 minutes in a standardized supine position on a nonconductive surface. The examination, lasting approximately 75 seconds, provided comprehensive data on body composition, including reliable fat-free mass measurements for our study population.

Kidney Disease Quality of Life Short Form

Administration of the KDQOL-SF involved addressing various dimensions of quality of life, including physical, social, emotional, cognitive, and satisfaction aspects. The questionnaire was verbally presented to the participants before and after 6 months of exercise protocol [26,27].

Statistical analyses

Before each statistical test, normality testing was conducted using the Kolmogorov-Smirnov test. The initial phase focused on assessing changes within the entire hemodiafiltration exercise group compared to controls. Descriptive statistics informed the baseline and postexercise variables, and month-to-month dialysis comparisons with two-way analysis of variance (ANOVA), and McNemar test for categorical variables. Following this, the study diverged into a comparative analysis between patients engaging in intradialytic exercise activities and those opting for sessions on non-dialysis days (interdialytic). The comparison involved two-way ANOVA for continuous variables and chi-square tests for categorical variables. For all analyses, p-values < 0.05 were considered statistically significant. All statistical analyses were conducted and analyzed by authors MFO and ATH.

Results

A total of 267 participants were recruited to engage in the exercise program. Among them, 81 (30.3%) declined to participate. From the enrolled 186 individuals, we further refined the cohort, excluding 64 patients (34.4%) based on several exclusion criteria (Fig. 2). The final analysis included 122 patients, of which 89 (73.0%) were in the exercise group and 33 (27.0%) were enrolled in the control group. Of those 89 patients who performed exercise, 54 patients (60.7%) engaged in the intradialytic exercise group, and 35 patients (39.3%) performed exercise outside of the hemodiafiltration (interdialytic exercise group).

Control versus exercise group analysis

There were no statistically significant differences in demographics, comorbidities, or medications among participants (Table 1). In the exercise group, 82.1% had arteriovenous fistula access for dialysis, compared to 66.7% in the control group (p > 0.05). There were no interruptions to the exercise protocol due to adverse events (i.e., hypotension, arrhythmia, reduced blood oxygenation, or arteriovenous fistula issues) in the exercise group for the duration of the study.
A comparison of the control group versus the exercise group (Fig. 3) shows statistically significant differences in dialysis efficiency parameters. Both control and exercise groups showed improvements in single-pool (Fig. 3A), standard (Fig. 3B), and equilibrated Kt/Vurea (Fig. 3C) from baseline to month 6; however, the increases were greater in the exercise group. Analysis of pre- and post-dialysis urea values revealed a trend toward improved urea clearance in the exercise group over the 6-month protocol. Pre-dialysis urea levels decreased from 126.3 ± 35.2 mg/dL at pre-rehabilitation (month 1) to 116.8 ± 29.8 mg/dL at post-rehabilitation protocol (month 6). Post-dialysis urea levels also reduced, from 41.7 ± 17.9 mg/dL at pre-rehabilitation (month 1) to 35.0 ± 15.0 mg/dL at post-rehabilitation protocol (month 6).
For all of the exercise variables measured in the exercise group, there was an increase in fat-free mass, handgrip strength, and number of steps completed in the step test (Table 2). Regarding patient-reported outcomes, there were statistically significant improvements in general health during the program (baseline vs. post-6-month exercise program: 55.74 ± 23.1 vs. 61.0 ± 21.5, p < 0.02), physical functioning (64.6 ± 22.1 vs. 72.3 ± 23.4, p < 0.01), and social function (72.8 ± 26.0 vs. 80.6 ± 21.0, p < 0.01). However, no statistically significant change in overall health (65.9 ± 20.7 vs. 67.9 ± 18.3, p > 0.05) or cognitive function (77.2 ± 22.3 vs. 79.6 ± 22.3, p > 0.05) were observed.

Interdialytic versus intradialytic group analysis

There were no statistically significant differences between participants in the interdialytic and intradialytic demographics and comorbidities throughout the study (Table 1). No differences were observed between interdialytic and intradialytic related to arteriovenous fistula for dialysis sessions (82.9% vs. 78.2%, respectively). We excluded people who participated with less than 80% adherence, with the intradialytic group showing 86.1% ± 5.2% compliance and the interdialytic group showing 87.0% ± 4.3% compliance, with no statistically significant difference between the groups (p = 0.55). We would like to emphasize that no adverse effects or changes in exercise performance were reported in relation to the timing of the exercise.
Kt/Vurea showed no statistically significant differences between the interdialytic and intradialytic groups, in either single-pool, standard, or equilibrated metrics (Table 3). On the other hand, both groups had statistically significant changes in the fat-free mass, step test, and handgrip measurements within both interdialytic and intradialytic (Table 2).
Although there was an overall improvement in quality of life between baseline and after the 6-month program assessments, there were no statistically significant increases in cognitive function scores in either group of the interdialytic (76.9 ± 24.3 vs. 79.8 ± 22.9, p > 0.05) or the intradialytic (77.4 ± 21.2 vs. 79.5 ± 22.2, p > 0.05). Similarly, no statistically significant differences were observed in overall health scores for both the interdialytic (65.7 ± 21.6 vs. 69.5 ± 18.4, p > 0.05) and the intradialytic (66.1 ± 20.2 vs. 66.9 ± 18.3, p > 0.05). However, the interdialytic group showed statistically significant increases in physical functioning (63.3 ± 23.0 vs. 71.1 ± 23.8, p < 0.05) and social function (69.1 ± 27.6 vs. 82.7 ± 21.3; p < 0.001), while the intradialytic group had statistically significant increase in physical functioning (65.4 ± 21.7 vs. 73.3 ± 23.3, p < 0.01) and general health (53.9 ± 23.1 vs. 60.1 ± 21.0, p < 0.02), but not in social function.

Discussion

This study aimed to evaluate if exercise was effective for patients utilizing hemodiafiltration, and secondly, to compare the benefits of exercise during or between dialysis sessions. Our results indicate increased dialysis efficiency and beneficial exercise metrics based on Kt/Vurea, step test, handgrip, and quality-of-life questionnaire results. There were statistically significant improvements in dialysis efficiency and patient-reported outcomes for all exercise participants. Notably, none of the participants experienced dialysis or exercise-related adverse events. Additionally, no differences were observed in exercise benefits when comparing timing, either interdialytic or intradialytic.
For patients utilizing dialysis, improved Kt/Vurea indicates more effective dialysis [28]. Dialysis is associated with a pro-inflammatory state which can lead to cardiovascular complications and increased mortality risk [29]. Current literature shows significant exercise benefits coupled with increased dialysis efficiency, by reducing the systemic inflammatory effect associated with dialysis [30,31]. Improved dialytic efficiency has been shown to have anti-inflammatory effects in chronic kidney disease patients utilizing hemodialysis [32,33]. Low-intensity exercise increases the removal of small solutes in hemodialysis patients [12]. As seen in our study, Kt/Vurea increased statistically significantly for all patients regardless of when exercise was performed vis-à-vis the dialysis window. Our patients utilized 70% of their maximal heart rate (moderate intensity), indicating increased clearance during the dialysis session. Even though the control group had increased Kt/Vurea, the exercise participants saw comparatively greater benefits, suggesting that exercise played an important role for this patient population. Our findings of improved exercise capacity and dialysis efficiency align with previous research on the benefits of intradialytic exercise in hemodialysis patients. Reboredo et al. [34] demonstrated that an intradialytic aerobic training program significantly improved exercise tolerance and oxygen uptake kinetics in patients with end-stage renal disease.
Utilizing exercise programs during dialysis sessions has been shown to be effective and reliable based on current literature. Our study goes deeper into this point. Importantly, we found no statistically significant differences in dialytic efficiency or exercise outcomes when directly comparing the intradialytic and interdialytic exercise subgroups. While intradialytic exercise is known to increase solute clearance through enhanced blood flow to low-perfusion areas like muscle and skin, our results suggest that the timing of exercise may not be the critical factor in improving dialysis efficiency for hemodiafiltration patients. This suggests that the key factor influencing better solute clearance and physical functioning was adherence to the prescribed exercise program, not the specific timing of exercise delivery. Regular exercise training, whether intradialytic or interdialytic, can improve microvascular perfusion and oxygen delivery to exercising muscles, thereby enhancing dialysis efficiency and overall exercise capacity in chronic kidney disease patients.
Improvements were previously seen in muscle mass and beneficial to muscle metabolic control and exercise tolerance [35]. More importantly, sarcopenia has been shown to be a predictor of mortality for patients with chronic conditions [36]. It has even been shown that exercise induces changes in body mass, and increases skeletal muscle quality and other adaptations, with resistance training [37,38]. Additionally, muscle functionality is lost before muscle mass and may be due to many catabolic mechanisms, such as systemic inflammation, acidosis, protein-energy malnutrition, comorbid illnesses, corticosteroid use, and dialysis [39]. Implementing exercise has been shown to improve muscle quality, strength, and the pro-inflammatory state [38]. Handgrip strength is shown to independently predict muscle strength, sarcopenia, mortality, and frailty [40]. Importantly, we had an increase in the handgrip test and fat-free mass, indicating improved muscle strength. This may also be due to nitric oxide bioavailability. Also, the observed increase in fat-free mass and muscle strength may have contributed to improved Kt/V values, as increased muscle mass can enhance solute removal and potentially reduce the risk of intradialytic hypotension, leading to more effective dialysis sessions [41]. Increasing muscle mass and function in chronic kidney disease patients can improve their quality of life, coupled with exercise benefits.
Implementing exercise with dialysis has shown increases in health-related quality of life symptoms [42]. Previous research indicates mixed and indecisive results as to whether interdialytic exercise has benefits for chronic kidney disease patients [16,19,20]. Our patients experienced statistically significant improvement in their social function, general health, and physical functioning, indicating an overall improvement in the quality of life of those on hemodiafiltration and exercise.

Clinical implications

This study demonstrates that implementing exercise as part of rehabilitation therapy is feasible for patients on maintenance hemodiafiltration. Additionally, exercise can be performed either during or in between dialysis sessions. We observed comparable improvements in exercise-related outcomes and dialysis adequacy measures like Kt/Vurea when directly comparing the intradialytic and interdialytic exercise groups. The observed improvements in both urea clearance and Kt/V suggest that the exercise protocol may have enhanced overall dialysis efficiency, potentially through increased blood flow and improved solute removal. The absence of statistically significant differences between these two exercise modalities (interdialytic and intradialytic) strongly suggests that adhering to a supervised exercise regimen, irrespective of whether it is performed intra- or inter-dialytically, is the key determinant of positive treatment effects in hemodiafiltration patients.
We believe that some similarities in the effects of exercise prescription between conventional hemodialysis and hemodiafiltration patients could be expected; however, there are potential differences that could be anticipated. Hemodiafiltration’s superior ability to remove both small and middle-sized molecules might lead to better exercise tolerance and potentially allow for more intense or longer exercise sessions. The improved hemodynamic stability associated with hemodiafiltration could result in better exercise tolerance during intradialytic sessions. Additionally, hemodiafiltration’s effectiveness in reducing inflammation and oxidative stress might contribute to improved exercise capacity and recovery.
However, it is important to note that our study focused specifically on hemodiafiltration patients and did not include a direct comparison with conventional hemodialysis patients. Our study demonstrates the benefits of exercise in hemodiafiltration patients, but further research directly comparing exercise effects in hemodialysis versus hemodiafiltration patients would be necessary to confirm these potential differences.

Study limitations

While this study employed reliable methods, including handgrip strength as a validated measure of muscle function in chronic kidney disease and Kt/Vurea as the gold standard for assessing dialysis adequacy, there are some limitations that warrant acknowledgment. Firstly, the lack of muscle cross-sectional area measurements and blood sample analyses for inflammatory markers (such as C-reactive protein or interleukin-6), nitric oxide levels, and oxidative stress indicators precluded a more comprehensive understanding of the exercise intervention’s effects on muscle morphology and biochemical pathways influencing dialysis efficiency. These markers could have provided additional insights into the physiological mechanisms underlying the observed improvements in dialysis efficiency and physical function. Additionally, our study focused exclusively on hemodiafiltration, and future research should explore the potential benefits of exercise training across other dialysis modalities.
A limitation of our study is the lack of detailed physiological measurements such as blood flow dynamics and solute kinetics. While we observed similar benefits in dialysis efficiency and physical function for both intradialytic and interdialytic exercise, the underlying mechanisms remain unclear. Intradialytic exercise could theoretically enhance solute clearance through increased muscle blood flow and capillary recruitment during the dialysis session. Conversely, interdialytic exercise might improve overall cardiovascular function and muscle metabolism (muscle blood flow and capillary recruitment), potentially contributing to better solute clearance during subsequent dialysis sessions. However, without specific measurements, these hypotheses remain speculative. The superior solute removal capabilities of hemodiafiltration may have minimized potential differences between exercise timings. Future research incorporating blood flow measurements, detailed solute kinetics, and markers of cardiovascular adaptation would be valuable in elucidating the specific physiological mechanisms underlying the benefits of exercise in hemodiafiltration patients.
Another limitation is the absence of long-term follow-up data, as our study only evaluated participants at baseline and after 6 months of the exercise program. Longitudinal assessments over an extended period could provide valuable insights into the maintenance of the observed improvements and the potential need for exercise program modifications or progressions to maintain or enhance the therapeutic effects.

Conclusion

This study demonstrated that exercise during hemodiafiltration is effective, yielding substantial improvements in patient-reported and performance outcomes. Notably, we observed significant increases in Kt/V values in the exercise group, indicating enhanced dialysis efficiency. The absence of statistically significant differences between intradialytic or interdialytic exercise programs suggests that adhering to a supervised exercise regimen is the key determinant of positive treatment effects in hemodiafiltration patients, regardless of timing. These findings underscore the importance of incorporating exercise as an adjunctive therapy in hemodiafiltration treatment.

Notes

Conflicts of interest

All authors have no conflicts of interest to declare.

Acknowledgments

Manuscript development was supported by the Arkansas INBRE program through an award from the National Institute of General Medical Sciences - NIGMS (P20 GM103429) - of the National Institutes of Health.

Data sharing statement

The data presented in this study are available from the corresponding author upon reasonable request.

Authors’ contributions

Conceptualization, Methodology: JLFA, RF, MFO

Data curation, Formal analysis: JLFA, ATH, MKR, RF, TR, MFO

Supervision: MFO

Investigation: JLFA, MKR, RF

Validation: DKM, AMR, BPB, MAG

Writing – Original Draft: All authors

Writing – Review & Editing: All authors

All authors read and approved the final manuscript.

Figure 1.

Exercise protocols for hemodiafiltration patients.

(A) Interdialytic exercise (performed between dialysis sessions). (B) Intradialytic exercise (conducted during dialysis sessions). Both protocols include aerobic and resistance training components.
j-krcp-24-243f1.jpg
Figure 2.

Flowchart of study participants, ultimately participants were placed into experimental groups.

j-krcp-24-243f2.jpg
Figure 3.

Control versus exercise group Kt/Vurea data across the 6-month exercise program.

(A) Single-pool Kt/Vurea (spKt/Vurea), (B) standard Kt/Vurea (stdKt/Vurea), and (C) equilibrated Kt/Vurea (eKt/Vurea).
*p < 0.05 vs. month 1. p < 0.05 control group vs. exercise group.
j-krcp-24-243f3.jpg
Table 1.
The baseline characteristics of all study participants and separated into their respective study groups
Anthropometry/demography Control group (n = 33) Exercise group (n = 89) p-value (control vs. exercise) Interdialytic group (n = 35) Intradialytic group (n = 54) p-value (inter vs. intra)
Male sex 24 (72.7) 52 (58.4) 0.495 22 (62.9) 30 (55.6) 0.52
Age (yr) 60 ± 17 54 ± 15 0.19 56 ± 16 53 ± 15 0.90
Weight (kg) 82 ± 20 76 ± 16 0.16 79 ± 17 74 ± 15 0.74
Height (m) 1.71 ± 0.10 1.68 ± 0.10 0.74 1.68 ± 0.12 1.69 ± 0.09 0.98
Body mass index (kg/m2) 27.1 ± 5.7 26.4 ± 4.6 0.65 27.7 ± 5.8 25.5 ± 3.5 0.65
Kidney disease vintage (mo) 132 ± 108 108 ± 84 0.19 96 ± 50 120 ± 70 0.19
Dialysis vintage (mo) 60 ± 36 60 ± 42 0.99 48 ± 30 68 ± 45 0.09
Comorbidity
 Polycystic kidneys 6 (18.2) 7 (7.9) 0.32 4 (11.4) 3 (5.6) 0.32
 Hypertension 22 (66.7) 69 (77.5) 0.27 25 (71.4) 44 (81.5) 0.27
 Diabetes 15 (45.5) 37 (41.6) 0.13 18 (51.4) 19 (35.2) 0.10
 Dyslipidemia 1 (3.0) 5 (5.6) 0.36 1 (2.9) 4 (7.4) 0.13
 Arrhythmia 0 (0) 6 (6.7) 0.76 2 (5.7) 4 (7.4) 0.76
 Active smoker 1 (3.0) 2 (2.2) 0.25 0 (0) 2 (3.7) 0.08
 Former smoker 3 (9.1) 8 (9.0) 0.39 2 (5.7) 6 (11.1) 0.39
 Previous angioplasty 2 (6.1) 6 (6.7) 0.76 2 (5.7) 4 (7.4) 0.66
 Chronic heart failure 7 (21.2) 4 (4.5) 0.55 1 (2.9) 3 (5.6) 0.55
Medications
 Hematopoietic stimulants 10 (30.3) 65 (73.0) 0.83 26 (74.3) 39 (72.2) 0.83
 Analgesics 1 (3.0) 4 (4.5) 0.65 4 (11.4) 0 (0) 0.01
 Anticoagulants 10 (30.3) 50 (56.2) 0.47 18 (51.4) 32 (59.3) 0.47
 Corticosteroids 6 (18.2) 10 (11.2) 0.46 5 (14.3) 5 (9.3) 0.46
 Antihypertensive 13 (39.4) 48 (53.9) 0.70 18 (51.4) 30 (55.6) 0.70
 Antiarrhythmics 8 (24.2) 16 (18.0) 0.06 3 (8.6) 13 (24.1) 0.06
 Diuretics 10 (30.3) 30 (33.7) 0.08 8 (22.9) 22 (40.7) 0.08

Data are expressed as number (%) or mean ± standard deviation.

The exercise group indicates all participants who performed exercise, whether intra- or inter-dialysis.

Table 2.
Exercise metrics for all participants and their respective groups, baseline, and post-analysis of the 6-month exercise program
Variable Before
After
Exercise (n = 89) Inter (n = 35) Intra (n = 54) Exercise (n = 89) Inter (n = 35) Intra (n = 54)
Fat-free mass (kg/m2) 13.9 ± 2.8 14.4 ± 3.2 13.6 ± 2.4 14.4 ± 2.71a 14.8 ± 3.3a 14.1 ± 2.2a
Step test (number of steps) 79.9 ± 22.6 84.1 ± 21.9 77.2 ± 22.8 92.6 ± 25.5a 95.7 ± 27.6a 90.7 ± 24.1a
Handgrip (N) 279.5 ± 78.0 282.4 ± 67.1 277.5 ± 85.7 295.2 ± 76.6a 302.1 ± 67.0a 291.3 ± 83.2a
Urea reduction ratio (%) 68.7 ± 10.5 68.1 ± 9.4 69.1 ± 11.2 71.1 ± 8.3a 71.5 ± 7.4a 70.9 ± 8.9
Hemoglobin (g/dL) 11.3 ± 1.5 11.1 ± 1.7 11.4 ± 1.4 11.6 ± 1.4 11.8 ± 1.5 11.4 ± 1.4

Data are expressed as mean ± standard deviation.

The exercise group indicates all participants who performed exercise, whether intra- or inter-dialysis.

aIt indicates statistical significance (p < 0.05) in the comparison between before (baseline) and after (month 6).

Table 3.
Kt/Vurea data for exercise participants and their study groups, intradialytic vs. interdialytic throughout the 6-month exercise program
Variable Month
1 2 3 4 5 6
Single-pool Kt/Vurea (a.u.)
 Interdialytic 1.26 ± 0.45 1.32 ± 0.48 1.42 ± 0.50a 1.48 ± 0.51a 1.49 ± 0.50a 1.52 ± 0.51a
 Intradialytic 1.22 ± 0.47 1.40 ± 0.50a 1.47 ± 0.50a 1.45 ± 0.50a 1.50 ± 0.51a 1.59 ± 0.58a
Standard Kt/Vurea (a.u.)
 Interdialytic 1.97 ± 0.32 1.97 ± 0.32 2.03 ± 0.32 2.07 ± 0.36 1.98 ± 0.32 2.13 ± 0.43a
 Intradialytic 1.86 ± 0.41 1.92 ± 0.27 1.92 ± 0.40 1.96 ± 0.41 1.98 ± 0.40a 2.10 ± 0.41a
Equilibrated Kt/Vurea (a.u.)
 Interdialytic 1.10 ± 0.30 1.13 ± 0.34 1.13± 0.34 1.13 ± 0.34 1.20 ± 0.41a 1.23 ± 0.43a
 Intradialytic 1.02 ± 0.32 1.10 ± 0.30 1.12 ± 0.33 1.16 ± 0.37a 1.16 ± 0.42a 1.12 ± 0.40a

Data are expressed as mean ± standard deviation.

The exercise group indicated all participants who performed exercise, whether intra- or inter-dialysis.

a.u., arbitrary unit.

aIt indicates statistical significance (p < 0.05) in the comparison between before (baseline) and after (month 6).

References

1. Thurlow JS, Joshi M, Yan G, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 2021;52:98–107.
crossref pdf
2. Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P. Unveiling the clinical benefits of high-volume hemodiafiltration: optimizing the removal of medium-weight uremic toxins and beyond. Toxins (Basel) 2023;15:531.
crossref
3. Blankestijn PJ, Vernooij RW, Hockham C, et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med 2023;389:700–709.
crossref
4. Liu A, Gelfand SL. Move it or lose it: intradialytic exercise as antidote to functional losses in hemodialysis patients? NEJM Evid 2023;2:EVIDe2300178.
crossref
5. Wu L, Liu Y, Wu L, Yang J, Jiang T, Li M. Effects of exercise on markers of inflammation and indicators of nutrition in patients with chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol 2022;54:815–826.
crossref pdf
6. von Gersdorff G, von Korn P, Duvinage A, et al. Cluster randomized controlled trial on the effects of 12 months of combined exercise training during hemodialysis in patients with chronic kidney disease-study protocol of the Dialysis Training Therapy (DiaTT) Trial. Methods Protoc 2021;4:60.
crossref
7. Pereira AB, Santana LL, Rocha LB, et al. Physical exercise affects quality of life and cardiac autonomic modulation in patients with chronic kidney failure submitted to hemodialysis: a randomized clinical trial. Percept Mot Skills 2022;129:696–713.
crossref pdf
8. Rochmawati E, Utomo EK, Makiyah SN. Improving dialysis adequacy and quality of life in patients undergoing hemodialysis with twice a week range of motion exercise. Ther Apher Dial 2022;26:140–146.
crossref pdf
9. Malini H, Forwaty E, Cleary M, Visentin D, Oktarina E, Lenggogeni DP. The effect of intradialytic range of motion exercise on dialysis adequacy and fatigue in hemodialysis patients. J Nurs Res 2022;30:e221.
crossref
10. Imamura K, Suzuki Y, Yamamoto S, et al. Feasibility of long-term intradialytic exercise for older patients receiving hemodialysis: a retrospective single-center study. Int Urol Nephrol 2022;54:907–916.
crossref pdf
11. Mallamaci F, D’Arrigo G, Tripepi G, et al. Long-term effect of physical exercise on the risk for hospitalization and death in dialysis patients: a post-trial long-term observational study. Clin J Am Soc Nephrol 2022;17:1176–1182.
crossref
12. Usui N, Uehata A, Nakata J, et al. Effect of blood volume change related to intensity of intradialytic aerobic exercise on hemodialysis adequacy: a pilot study. Int Urol Nephrol 2022;54:1427–1434.
crossref pdf
13. Otobe Y, Rhee CM, Nguyen M, Kalantar-Zadeh K, Kopple JD. Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients. Curr Opin Nephrol Hypertens 2022;31:109–128.
crossref
14. Arroyo E, Umukoro PE, Burney HN, et al. Initiation of dialysis is associated with impaired cardiovascular functional capacity. J Am Heart Assoc 2022;11:e025656.
crossref
15. Lambert K, Lightfoot CJ, Jegatheesan DK, Gabrys I, Bennett PN. Physical activity and exercise recommendations for people receiving dialysis: a scoping review. PLoS One 2022;17:e0267290.
crossref
16. Greenwood SA, Koufaki P, Macdonald J, et al. The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial. Clin Kidney J 2020;14:1345–1355.
crossref pdf
17. Bellizzi V, Regolisti G. What is the role of exercise in chronic kidney disease? Nephrol Dial Transplant 2022;37:258–261.
crossref pdf
18. Abdelbasset WK, Ibrahim AA, Althomali OW, Hussein HM, Alrawaili SM, Alsubaie SF. Effect of twelve-week concurrent aerobic and resisted exercise training in non-dialysis day on functional capacity and quality of life in chronic kidney disease patients. Eur Rev Med Pharmacol Sci 2022;26:6098–6106.
crossref pmid
19. Takahashi R, Yabe H, Ishikawa H, et al. Factors associated with improved health-related quality of life due to improvements in physical function and dialysis-related symptoms following intradialytic exercise in outpatients undergoing haemodialysis. Qual Life Res 2024;33:1133–1142.
crossref pdf
20. Greenwood SA, Koufaki P, Macdonald JH, et al. Randomized trial-PrEscription of intraDialytic exercise to improve quAlity of Life in patients receiving hemodialysis. Kidney Int Rep 2021;6:2159–2170.
crossref
21. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2:295–304.
crossref
22. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377–381.
crossref
23. Levinger I, Goodman C, Hare DL, Jerums G, Toia D, Selig S. The reliability of the 1RM strength test for untrained middle-aged individuals. J Sci Med Sport 2009;12:310–316.
crossref
24. American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. 11th ed. Wolters Kluwer; 2021.
25. Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 2011;40:423–429.
crossref
26. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994;3:329–338.
crossref pdf
27. Duarte PS, Ciconelli RM, Sesso R. Cultural adaptation and validation of the “Kidney Disease and Quality of Life-Short Form (KDQOL-SF 1.3)” in Brazil. Braz J Med Biol Res 2005;38:261–270.
crossref
28. Daugirdas JT, Blake PG, Ing TS. Handbook of dialysis. 5th ed. Wolters Kluwer Health; 2014.
29. Sárközy M, Kovács ZZ, Kovács MG, Gáspár R, Szűcs G, Dux L. Mechanisms and modulation of oxidative/nitrative stress in type 4 cardio-renal syndrome and renal sarcopenia. Front Physiol 2018;9:1648.
30. Costanti-Nascimento AC, Brelaz-Abreu L, Bragança-Jardim E, Pereira WO, Camara NO, Amano MT. Physical exercise as a friend not a foe in acute kidney diseases through immune system modulation. Front Immunol 2023;14:1212163.
crossref
31. Bogataj Š, Pajek J, Buturović Ponikvar J, Pajek M. Functional training added to intradialytic cycling lowers low-density lipoprotein cholesterol and improves dialysis adequacy: a randomized controlled trial. BMC Nephrol 2020;21:352.
crossref pdf
32. Baião VM, Cunha VA, Duarte MP, et al. Effects of exercise on inflammatory markers in individuals with chronic kidney disease: a systematic review and meta-analysis. Metabolites 2023;13:795.
crossref
33. Dong ZJ, Zhang HL, Yin LX. Effects of intradialytic resistance exercise on systemic inflammation in maintenance hemodialysis patients with sarcopenia: a randomized controlled trial. Int Urol Nephrol 2019;51:1415–1424.
crossref pdf
34. Reboredo MM, Neder JA, Pinheiro BV, Henrique DM, Lovisi JC, Paula RB. Intra-dialytic training accelerates oxygen uptake kinetics in hemodialysis patients. Eur J Prev Cardiol 2015;22:912–919.
crossref pdf
35. Hirai DM, Copp SW, Ferreira LF, Musch TI, Poole DC. Nitric oxide bioavailability modulates the dynamics of microvascular oxygen exchange during recovery from contractions. Acta Physiol (Oxf) 2010;200:159–169.
crossref
36. Hsu BG, Wang CH, Lai YH, Kuo CH, Lin YL. Association of endothelial dysfunction and peripheral arterial disease with sarcopenia in chronic kidney disease. J Cachexia Sarcopenia Muscle 2024;15:1199–1208.
crossref
37. Baião VM, Duarte MP, Cunha VA, et al. Intradialytic resistance training for short daily hemodialysis patients as part of the clinical routine: a quasi-experimental study. Front Aging 2023;4:1130909.
crossref pmid
38. Cheema B, Abas H, Smith B, et al. Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol 2007;18:1594–1601.
crossref pmid
39. Sánchez-Tocino ML, González-Parra E, Miranda Serrano B, et al. Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patients. Clin Kidney J 2022;15:1514–1523.
crossref pdf
40. Chen H, Zhang F, Huang L, Bai Y, Zhong Y, Li Y. Thresholds of handgrip strength for all-cause mortality in patients with chronic kidney disease: a secondary systematic review with dose-response meta-analysis. Ren Fail 2024;46:2305855.
crossref
41. Kirkman DL, Mullins P, Junglee NA, Kumwenda M, Jibani MM, Macdonald JH. Anabolic exercise in haemodialysis patients: a randomised controlled pilot study. J Cachexia Sarcopenia Muscle 2014;5:199–207.
crossref
42. Rossum K, Hancock E, Thompson S, et al. A randomized trial examining the impact of timing of intradialytic cycling on intradialytic hypotension. Kidney Int Rep 2023;8:1002–1012.
crossref


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2026 by The Korean Society of Nephrology.

Developed in M2PI

Close layer